Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Common stock, par value $0.001 per share
-
Shares outstanding
-
5.43M
-
Number of holders
-
62
-
Total 13F shares, excl. options
-
16.6M
-
Shares change
-
+253K
-
Total reported value, excl. options
-
$399M
-
Value change
-
+$3.16M
-
Number of buys
-
30
-
Number of sells
-
-24
-
Price
-
$24.06
Significant Holders of Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share (APRE) as of Q3 2020
72 filings reported holding APRE - Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share as of Q3 2020.
Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share (APRE) has 62 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16.6M shares
.
Largest 10 shareholders include FMR LLC (3.16M shares), Redmile Group, LLC (2.27M shares), 5AM Venture Management, LLC (2.21M shares), Versant Venture Management, LLC (1.85M shares), Consonance Capital Management LP (1.46M shares), Sectoral Asset Management Inc (916K shares), JANUS HENDERSON GROUP PLC (851K shares), VANGUARD GROUP INC (643K shares), Rock Springs Capital Management LP (518K shares), and BlackRock Inc. (488K shares).
This table shows the top 62 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.